2022
DOI: 10.1016/j.vaccine.2022.03.058
|View full text |Cite
|
Sign up to set email alerts
|

Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
6
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 30 publications
3
6
1
Order By: Relevance
“…Taken alone, age continues to be positively associated with influenza and COVID-19 vaccination uptake among HCWs, as also confirmed in other national and international studies [15,17,21,22,33,37]. This is also confirmed in the multivariable logistic regression for influenza, but for COVID-19 vaccination, age was no longer a predictor of getting vaccinated during the 2020/ 21 season.…”
Section: Vaccination Status By Profession Language and Agesupporting
confidence: 78%
“…Taken alone, age continues to be positively associated with influenza and COVID-19 vaccination uptake among HCWs, as also confirmed in other national and international studies [15,17,21,22,33,37]. This is also confirmed in the multivariable logistic regression for influenza, but for COVID-19 vaccination, age was no longer a predictor of getting vaccinated during the 2020/ 21 season.…”
Section: Vaccination Status By Profession Language and Agesupporting
confidence: 78%
“…COVID-19 vaccination was highest among those who historically always received the influenza vaccine, reinforcing studies showing shorter-term correlation between influenza and COVID-19 vaccination. 4 , 5 Most strikingly, among individuals who historically never got the influenza vaccine, those receiving COVID-19 vaccine were substantially more likely to switch toward getting the influenza vaccine. This suggests that investing in vaccine acceptance has payoffs beyond the vaccine itself.…”
Section: Discussionmentioning
confidence: 99%
“…The dramatic reduction in the circulation of all the non-SARS-CoV-2 respiratory pathogens seen worldwide in the first months after the onset of the COVID-19 pandemic should mainly be attributed to the introduction of NPIs. No new preventive pharmacological measures against the infections caused by these pathogens had been introduced and influenza vaccination coverage, albeit with differences among countries, generally aligned with local vaccination history or was only slightly higher than in the pre-pandemic era [ 61 , 62 ]. However, defining which were the most effective measures and how much they affected the spread of the pathogens, together with the containment of COVID-19 cases, remains very difficult, if not impossible [ 63 ].…”
Section: Reasons For Variations In Epidemiology Of Non-sars-cov-2 Vir...mentioning
confidence: 99%